Related references
Note: Only part of the references are listed.Induced regulatory T cells suppress Tc1 cells through TGF-β signaling to ameliorate STZ-induced type 1 diabetes mellitus
Li Zhou et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice
Fernanda M. C. Sodre et al.
DIABETES (2021)
Impaired Activated/Memory Regulatory T Cell Clonal Expansion Instigates Diabetes in NOD Mice
Vanessa Mhanna et al.
DIABETES (2021)
Progress in Translational Regulatory T Cell Therapies for Type 1 Diabetes and Islet Transplantation
Braulio A. Marfil-Garza et al.
ENDOCRINE REVIEWS (2021)
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial
Robin Assfalg et al.
DIABETOLOGIA (2021)
Thymic origins of autoimmunity-lessons from inborn errors of immunity
Rosa Bacchetta et al.
SEMINARS IN IMMUNOPATHOLOGY (2021)
Thymus and autoimmunity
Alexander Marx et al.
SEMINARS IN IMMUNOPATHOLOGY (2021)
The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes
Matthew Clark et al.
FRONTIERS IN IMMUNOLOGY (2021)
Emerging Therapeutic Strategies to Restore Regulatory T Cell Control of Islet Autoimmunity in Type 1 Diabetes
Victoria Volfson-Sedletsky et al.
FRONTIERS IN IMMUNOLOGY (2021)
Valproic Acid Suppresses Autoimmune Recurrence and Allograft Rejection in Islet Transplantation through Induction of the Differentiation of Regulatory T Cells and Can Be Used in Cell Therapy for Type 1 Diabetes
Jeng-Rong Lin et al.
PHARMACEUTICALS (2021)
Strategies for durable β cell replacement in type 1 diabetes
Todd M. Brusko et al.
SCIENCE (2021)
Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes
Ivana Stojanovic et al.
FRONTIERS IN IMMUNOLOGY (2021)
Antigen-Specific Treg Therapy in Type 1 Diabetes - Challenges and Opportunities
Isabelle Serr et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Effect of Immunosuppressive Adjuvant Kynurenine on Type 1 Diabetes Vaccine
Jing Sun et al.
FRONTIERS IN IMMUNOLOGY (2021)
Low-dose interleukin-2 -loaded nanoparticle effect on NK and T-reg cell expression in experimentally induced type 1 diabetes mellitus
Salma Aboelnazar et al.
GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY (2021)
InsB9-23 Gene Transfer to Hepatocyte-Based Combined Therapy Abrogates Recurrence of Type 1 Diabetes After Islet Transplantation
Fabio Russo et al.
DIABETES (2021)
Immunomodulation Followed by Antigen-Specific Treg Infusion Controls Islet Autoimmunity
Cecilia Cabello-Kindelan et al.
DIABETES (2020)
Regulatory T Cell Development
Peter A. Savage et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy
Mateusz Gliwinski et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
Type 1 diabetes-early life origins and changing epidemiology
Jill M. Norris et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study
Michelle Rosenzwajg et al.
DIABETOLOGIA (2020)
Mapping of Type 1 Diabetes Mellitus
Shivani Desai et al.
CURRENT DIABETES REVIEWS (2020)
Peptidase inhibitor 16 identifies a human regulatory T-cell subset with reduced FOXP3 expression over the first year of recent onset type 1 diabetes
Christoper M. Hope et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Hematopoietic stem cell transplantation recovers insulin deficiency in type 1 diabetes mellitus associated with IPEX syndrome
Takeru Yamauchi et al.
PEDIATRIC DIABETES (2019)
Potential effects of microbial air quality on the number of new cases of diabetes type I in children in two regions of Poland: a pilot study
Malgorzata Michalska et al.
INFECTION AND DRUG RESISTANCE (2019)
Orally delivered all-trans-retinoic acid- and transforming growth factor-β-loaded microparticles ameliorate type 1 diabetes in mice
Ivan Koprivica et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
FOXP3+Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children
Tyyne Viisanen et al.
FRONTIERS IN IMMUNOLOGY (2019)
Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective
Hua Yu et al.
IMMUNOLOGY (2018)
Treatment of T1D via optimized expansion of antigen- specific Tregs induced by IL-2/anti-IL-2 monoclonal antibody complexes and peptide/MHC tetramers
Cristina Izquierdo et al.
SCIENTIFIC REPORTS (2018)
Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development
Hua Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
Mohammad Alhadj Ali et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Avidity and Bystander Suppressive Capacity of Human Regulatory T Cell Expressing De Novo Autoreactive T-Cell Receptors in Type 1 Diabetes
Wen-I Yeh et al.
FRONTIERS IN IMMUNOLOGY (2017)
Regulatory T cells induced by B cells: a novel subpopulation of regulatory T cells
Chien-Hui Chien et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?
Caroline M. Hull et al.
DIABETOLOGIA (2017)
The role of FOXP3 in autoimmunity
Anne M. Pesenacker et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes
Michael J. Haller et al.
DIABETES (2016)
Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside
Chantal Kuhn et al.
IMMUNOTHERAPY (2016)
Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes
Natalia Marek-Trzonkowska et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
An essential role for the IL-2 receptor in Treg cell function
Takatoshi Chinen et al.
NATURE IMMUNOLOGY (2016)
The role of the intestinal microbiota in type 1 diabetes mellitus
Mikael Knip et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
John A. Todd et al.
PLOS MEDICINE (2016)
Development of Auto Antigen-specific Regulatory T Cells for Diabetes Immunotherapy
Jianxun Song
IMMUNE NETWORK (2016)
Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model
V. B. Gibson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Adult-onset type 1 diabetes patients display decreased IGRP-specific Tr1 cells in blood
Daisuke Chujo et al.
CLINICAL IMMUNOLOGY (2015)
Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms
Jamie B. Spangler et al.
IMMUNITY (2015)
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Jeffrey A. Bluestone et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes
Michael J. Haller et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Therapy of type 1 diabetes with CD4+CD25high CD127-regulatory T cells prolongs survival of pancreatic islets - Results of one year follow-up
Natalia Marek-Trzonkowska et al.
CLINICAL IMMUNOLOGY (2014)
Alteration of Regulatory T Cells in Type 1 Diabetes Mellitus: A Comprehensive Review
Tingting Tan et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2014)
Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review
Renecia A. Watkins et al.
TRANSLATIONAL RESEARCH (2014)
Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
Kevan C. Herold et al.
DIABETES (2013)
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
Agnes Hartemann et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Mecnanisms underlying CD4+Treg immune regulation in the adult: from experiments to models
Marta Caridade et al.
FRONTIERS IN IMMUNOLOGY (2013)
Administration of CD4+CD25highCD127- Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children
Natalia Marek-Trzonkowska et al.
DIABETES CARE (2012)
T Cell Receptor αβ Diversity Inversely Correlates with Pathogen-Specific Antibody Levels in Human Cytomegalovirus Infection
George C. Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Generation of Induced Regulatory T Cells from Primary Human Naive and Memory T Cells
Gavin I. Ellis et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
The Time Is Crucial for Ex Vivo Expansion of T Regulatory Cells for Therapy
Natalia Marek et al.
CELL TRANSPLANTATION (2011)
Phase 1 (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients
Nick Giannoukakis et al.
DIABETES CARE (2011)
Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3- and Foxp3+ Regulatory CD4+ T Cells in an Interleukin-10-Dependent Manner
Samuel Huber et al.
IMMUNITY (2011)
IFN-γ and IL-10 islet-antigen-specific T cell responses in autoantibody-negative first-degree relatives of patients with type 1 diabetes
L. G. Petrich de Marquesini et al.
DIABETOLOGIA (2010)
Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy
Tihamer Orban et al.
JOURNAL OF AUTOIMMUNITY (2010)
The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27
Lionel Apetoh et al.
NATURE IMMUNOLOGY (2010)
Disturbances in some Gene Expression in T Regulatory Cells Separated from Children with Metabolic Syndrome
W. Luczynski et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
CD4+CD25+CD127low/- regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression
Li-Song Shen et al.
CLINICAL IMMUNOLOGY (2009)
Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions
Joao H. Duarte et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation
Todd Brusko et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The T-cell receptor repertoire of regulatory T cells
Rafal Pacholczyk et al.
IMMUNOLOGY (2008)
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Lauren W. Collison et al.
NATURE (2007)
Dynamic changes in CD4+ CD25+high T cell apoptosis after the diagnosis of type 1 diabetes
S. Glisic-Milosavljevic et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance
Xuefang Cao et al.
IMMUNITY (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Induction of tolerance in type 1 diabetes via both CD4+ CD25+ T regulatory cells and T regulatory type 1 cells
Manuela Battaglia et al.
DIABETES (2006)
CD4+CD25high regulatory T cells in human autoimmune diabetes
AL Putnam et al.
JOURNAL OF AUTOIMMUNITY (2005)
Human CD4+CD25+ regulatory T cells
C Baecher-Allan et al.
SEMINARS IN IMMUNOLOGY (2004)
In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes
QZ Tang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
AL Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes
C Chen et al.
JOURNAL OF IMMUNOLOGY (2003)
Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide
NR Martinez et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Inhibition of human CD4+CD25+high regulatory T cell function
C Baecher-Allan et al.
JOURNAL OF IMMUNOLOGY (2002)
Infectious tolerance:: Human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells
H Jonuleit et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
CL Bennett et al.
NATURE GENETICS (2001)
Share Paper
